The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

Bluebird urged shareholders to back a take-private deal that could close imminently. Elsewhere, Unity Biotechnology began a strategic review and Mersana announced plans to cut more than half its ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.